Found: 5
Select item for more details and to access through your institution.
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0317-7
- By:
- Publication type:
- Article
PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0270-x
- By:
- Publication type:
- Article
Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093933
- By:
- Publication type:
- Article
Diagnostic and Prognostic Value of <i>SHOX2</i> and <i>SEPT9</i> DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084225
- By:
- Publication type:
- Article
Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077771
- By:
- Publication type:
- Article